Cargando…
How Autoantibodies Regulate Osteoclast Induced Bone Loss in Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a chronic inflammatory disease, characterized by autoimmunity that triggers joint inflammation and tissue destruction. Traditional concepts of RA pathogenesis have strongly been focused on inflammation. However, more recent evidence suggests that autoimmunity per se modu...
Autores principales: | Steffen, Ulrike, Schett, Georg, Bozec, Aline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6619397/ https://www.ncbi.nlm.nih.gov/pubmed/31333647 http://dx.doi.org/10.3389/fimmu.2019.01483 |
Ejemplares similares
-
Autoantibodies in Rheumatoid Arthritis: Historical Background and Novel Findings
por: Sokolova, Maria V., et al.
Publicado: (2021) -
The soluble CD83 protein prevents bone destruction by inhibiting the formation of osteoclasts and inducing resolution of inflammation in arthritis
por: Royzman, Dmytro, et al.
Publicado: (2022) -
Cells of the synovium in rheumatoid arthritis. Osteoclasts
por: Schett, Georg
Publicado: (2007) -
Regulation of differentiation and generation of osteoclasts in rheumatoid arthritis
por: Niu, Qing, et al.
Publicado: (2022) -
Inflammatory activation of the FcγR and IFNγR pathways co-influences the differentiation and activity of osteoclasts
por: Groetsch, Bettina, et al.
Publicado: (2022)